𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy

✍ Scribed by M. L. Alves Pedroso; A. B. W. Boldt; L. Pereira-Ferrari; R. Steffensen; E. Strauss; J. C. Jensenius; S. O. Ioshii; I. Messias-Reason

Book ID
108699797
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
151 KB
Volume
152
Category
Article
ISSN
0009-9104

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship of the genomic complexity o
Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon
✍ Francesc-Xavier López-Labrador; Sergi Ampurdanès; Mireia Giménez-Barcons; Magdal 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 3 views

In patients with chronic hepatitis C, the influence of the genetic heterogeneity of the hepatitis C virus (HCV) on the progression of liver disease and on the responsiveness to interferon therapy is a matter of controversy. In this study we evaluated the genetic complexity of HCV by singlestrand con

Usefulness of simple assays for serum co
Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy
✍ Toshio Suzuki; Eiji Tanaka; Akihiro Matsumoto; Akihiko Urushihara; Takeshi Sodey 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzyme‐linked immunosorbent assay based on genotype‐specific recombinant peptides of the NS4

Severity of liver disease predicts the d
Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy
✍ Wassim Chehadeh; Widad Al-Nakib 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

## Abstract A higher prevalence of glucose abnormalities has been reported in patients with hepatitis C virus (HCV) infection compared to patients with hepatitis B virus (HBV) infection. However, previous studies considered some confounding factors and ignored others, which might influence the comp

Randomized trial of high-dose interferon
Randomized trial of high-dose interferon-α-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy
✍ Nami Mori; Michio Imamura; Yoshiiku Kawakami; Hiromi Saneto; Tomokazu Kawaoka; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

## Abstract The aim of this study was to compare the efficacy of high‐dose interferon (IFN)‐α‐2b with standard dose of IFN‐α‐2b in combination with ribavirin (RBV) for patients with chronic hepatitis C virus (HCV) infection, and to investigate the predictive factors associated with virological resp

Prevalence of hepatitis C virus genotype
Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin
✍ Kazuhiko Hayashi; Yoshiaki Katano; Teiji Kuzuya; Yoshihiko Tachi; Takashi Honda; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## Abstract Hepatitis C virus (HCV) genotype 1a is rare in Japanese patients and the clinical characteristics of this genotype remain unclear. The interferon (IFN) sensitivity‐determining region (ISDR) and single‐nucleotide polymorphisms (SNPs) of interleukin‐28B (IL28B) among patients with HCV gen